Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
Search or
𝛼
SK
SIGN UP
SIGN IN
ENTITY
SMARTSCORE: 2.4/5
Mesoblast Ltd (MSB AU)
Watchlist
Contact IR
68
Analysis
Health Care
•
Australia
Mesoblast Limited provides biomedical services. The Company develops drugs for cardiovascular diseases, oncology, hematology, and spine orthopedic disorders treatment. Mesoblast conducts its business worldwide.
more
Watchlist
Contact IR
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Mesoblast Ltd
•
07 Aug 2022 10:52
Mesoblast (MSB AU): Trading Halt; Decreased Net Cash Usage in Q4; Positive Clinical Trial Results
Mesoblast intends to undertake a private placement. Currently, funding is available for an estimated seven quarters. Its net operating cash usage...
Tina Banerjee
Follow
338 Views
Share
bullish
•
AVZ Minerals
•
04 Mar 2022 11:21
S&P/ASX Indices: March 2022 Index Changes and Trading Strategy
A look at the S&P ASX Index March 2022 index constituent changes and discussion on potential trading strategies to generated market-neutral returns.
Janaghan Jeyakumar, CFA
Follow
605 Views
Share
bullish
•
CIMIC Group Ltd
•
23 Feb 2022 15:33
CIMIC (CIM AU) Replacement in ASX200
CIMIC's takeover by Hochtief triggers another index change in ASX200 - likely sometime in April. This brings forward the first intra-quarter ASX200...
Travis Lundy
Follow
363 Views
Share
bullish
•
Nongfu Spring
•
19 Feb 2022 20:23
Index Rebalance & ETF Flow Recap: HSI, HSCEI, HSTECH, HSCI, S&P/ASX, SET50, LIC, SBI Sumishin, Crown
This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...
Brian Freitas
Follow
596 Views
Share
bullish
•
HomeCo Daily Needs REIT
•
19 Feb 2022 14:40
The Weird Ways of the Aventus/HomeCo Daily Needs Index Rebalances (ASX200)
Aventus and Homeco Daily Needs now have the last doc/approval needed to proceed with their merger. The last day of trading for Aventus is 23 Feb....
Travis Lundy
Follow
416 Views
Share
First
Previous
4
5
6
7
8
9
10
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.56.3
x